Immunotech Biopharm Ltd (HK:6978) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Immunotech Biopharm Ltd announced that all resolutions proposed at their Annual General Meeting (AGM) on May 24, 2024, were unanimously passed by shareholders. Key resolutions included the adoption of audited financial statements, re-election of board directors, and authorization to issue and repurchase company shares. The approval of these resolutions signals strong shareholder confidence in the company’s leadership and strategic direction.
For further insights into HK:6978 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue